Literature DB >> 31663822

Inpatient eDermatology (Teledermatology) Can Help Meet the Demand for Inpatient Skin Disease.

Corey Georgesen1, Sabrina A Karim2, Rebecca Liu2, Autumn Moorhead1, Louis D Falo1,3,4,5,6, Joseph C English1.   

Abstract

Background: Currently, the number of inpatient dermatology providers cannot meet the overall burden of inpatient skin disease in the United States. Introduction: We seek to determine whether inpatient eDermatology can meet the need for inpatient skin disease in hospitals without access to a dermatology hospitalist.
Methods: This retrospective cohort study reviewed inpatient eDermatology consults at the University of Pittsburgh eDermatology Consult Service between July 1, 2014 and June 30, 2018. This included a diverse group of 1,320 patients admitted to 10 different community hospitals. Study data were reviewed for demographics, diagnostic impressions, time to discharge, and diagnostic discordance between referring and consultant physicians.
Results: Forty percent of inpatient eDermatology consults were admitted with a primary dermatologic diagnosis. Referring diagnosis most commonly was rash not otherwise specified. eDermatology consulting impressions, conversely, were specific and varied. Ninety-one percent of patients received a consultant impression by the end of day, or within 8 hours. Overall, 89.3% of patients with a referring diagnosis of "cellulitis" were given a different diagnosis by the consultant. Discussion: Although this study lacked concordance data to compare the Inpatient eDermatologist with a live Inpatient Dermatologist, overall, eDermatology consultants were able to provide rapid consult recommendations that aided patient management. Conclusions: Inpatient eDermatology appears to be an effective medium to provide dermatologic care to patients at hospitals without a dermatology presence. This delivery of health care can help prevent misdiagnosis, unnecessary costs, and inappropriate systemic therapies.

Entities:  

Keywords:  dermatology; e-health; teledermatology; telehealth; telemedicine

Mesh:

Year:  2019        PMID: 31663822     DOI: 10.1089/tmj.2019.0147

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  7 in total

1.  Rapid Implementation of an Inpatient Telehealth Program during the COVID-19 Pandemic.

Authors:  Jonathan D Hron; Chase R Parsons; Lee Ann Williams; Marvin B Harper; Fabienne C Bourgeois
Journal:  Appl Clin Inform       Date:  2020-07-01       Impact factor: 2.342

2.  Inpatient teledermatology improves diagnostic accuracy and management of erythroderma in hospitalized patients.

Authors:  H Khosravi; M B Nekooie; A Moorhead; J C English
Journal:  Clin Exp Dermatol       Date:  2021-09-10       Impact factor: 4.481

3.  Inpatient Telehealth Experience of Patients With Limited English Proficiency: Cross-sectional Survey and Semistructured Interview Study.

Authors:  Lily Payvandi; Chase Parsons; Fabienne C Bourgeois; Jonathan D Hron
Journal:  JMIR Form Res       Date:  2022-04-19

4.  Inpatient Dermatology Consultations in a General Surgery Ward in a Tertiary Hospital in China: A Retrospective Study of 251 Patients.

Authors:  Hanlin Zhang; Keyun Tang; Rouyu Fang; Hongzhong Jin; Qiuning Sun
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-22

Review 5.  Inpatient Teledermatology: a Review.

Authors:  Joseph Mocharnuk; Trevor Lockard; Corey Georgesen; Joseph C English
Journal:  Curr Dermatol Rep       Date:  2022-04-02

6.  Teledermatology to Facilitate Patient Care Transitions From Inpatient to Outpatient Dermatology: Mixed Methods Evaluation.

Authors:  Samantha M R Kling; Erika A Saliba-Gustafsson; Marcy Winget; Maria A Aleshin; Donn W Garvert; Alexis Amano; Cati G Brown-Johnson; Bernice Y Kwong; Ana Calugar; Ghida El-Banna; Jonathan G Shaw; Steven M Asch; Justin M Ko
Journal:  J Med Internet Res       Date:  2022-08-03       Impact factor: 7.076

7.  International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.

Authors:  Sara Lewin; Charles Lees; Miguel Regueiro; Ailsa Hart; Uma Mahadevan
Journal:  J Crohns Colitis       Date:  2020-10-21       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.